# | Title | Journal | Year | Citations |
---|
1 | Development of the Proteasome Inhibitor Velcade™ (Bortezomib) | Cancer Investigation | 2004 | 589 |
2 | Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy | Cancer Investigation | 2001 | 506 |
3 | Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer | Cancer Investigation | 2000 | 438 |
4 | Soy Isoflavones and Cancer Prevention | Cancer Investigation | 2003 | 341 |
5 | Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer | Cancer Investigation | 2005 | 341 |
6 | The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells | Cancer Investigation | 2013 | 312 |
7 | Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development | Cancer Investigation | 2005 | 293 |
8 | Cell Adhesion Molecules: Role and Clinical Significance in Cancer | Cancer Investigation | 2009 | 280 |
9 | The First 1000 Dendritic Cell Vaccinees | Cancer Investigation | 2003 | 269 |
10 | Current Treatment of Osteosarcoma | Cancer Investigation | 2001 | 266 |
11 | Methylation of the O6Position of Guanine in DNA is the Most Likely Initiating Event in Carcinogenesis by Methylating Agents | Cancer Investigation | 1984 | 261 |
12 | Quality of Life in Cancer: Definition, Purpose, and Method of Measurement | Cancer Investigation | 1993 | 258 |
13 | Possible Role of Oxidative Damage in Metal-Induced Carcinogenesis | Cancer Investigation | 1995 | 258 |
14 | The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis? | Cancer Investigation | 1992 | 255 |
15 | Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets | Cancer Investigation | 2012 | 253 |
16 | Suppression of Tumor Cell Growth by Anthocyanins In Vitro | Cancer Investigation | 1995 | 245 |
17 | Taxanes: A New Class of Antitumor Agents | Cancer Investigation | 1995 | 243 |
18 | The HER-2/neuOncogene in Tumors of the Gastrointestinal Tract | Cancer Investigation | 2001 | 236 |
19 | The Response of the Microvascular System to Radiation: A Review | Cancer Investigation | 1989 | 226 |
20 | The Epidemiology of Cancer Pain | Cancer Investigation | 2005 | 225 |
21 | Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin | Cancer Investigation | 2011 | 223 |
22 | Mitochondrial DNA Alterations in Cancer | Cancer Investigation | 2002 | 216 |
23 | Pathologic and Clinical Spectrum of Post-Thymic T-Cell Malignancies | Cancer Investigation | 1984 | 212 |
24 | Comprehensive Criteria for Assessing Therapy-Induced Toxicity | Cancer Investigation | 1990 | 209 |
25 | Quercetin Inhibit Human SW480 Colon Cancer Growth in Association with Inhibition of Cyclin D1and Survivin Expression through Wnt/β-Catenin Signaling Pathway | Cancer Investigation | 2009 | 206 |
26 | Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer | Cancer Investigation | 2009 | 205 |
27 | Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase Inhibitors | Cancer Investigation | 1994 | 204 |
28 | Characterization of a New Primary Human Pancreatic Tumor Line | Cancer Investigation | 1986 | 203 |
29 | Menstrual Factors and Risk of Breast Cancer | Cancer Investigation | 1988 | 203 |
30 | Magnetic Resonance Imaging Detects Suppression of Tumor Vascular Permeability After Administration of Antibody to Vascular Endothelial Growth Factor | Cancer Investigation | 1998 | 198 |
31 | Health Literacy and Shared Decision Making for Prostate Cancer Patients with Low Socioeconomic Status | Cancer Investigation | 2001 | 195 |
32 | The Problem of Post-Breast Cancer Lymphedema: Impact and Measurement Issues | Cancer Investigation | 2005 | 190 |
33 | Assessment of Breast Cancer-Related Arm Lymphedema—Comparison of Physical Measurement Methods and Self-Report | Cancer Investigation | 2010 | 188 |
34 | Environmental and Genetic Risk Factors for Childhood Leukemia: Appraising the Evidence | Cancer Investigation | 2005 | 187 |
35 | Psychosocial Issues: An International Survey of Physician Attitudes and Practice in Regard to Revealing the Diagnosis of Cancer | Cancer Investigation | 1987 | 185 |
36 | Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer | Cancer Investigation | 2001 | 183 |
37 | Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer | Cancer Investigation | 2013 | 179 |
38 | Mechanisms of Carcinogenesis and Clinical Features of Asbestos-Associated Cancers | Cancer Investigation | 1996 | 178 |
39 | Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/neu | Cancer Investigation | 2004 | 176 |
40 | The New Bisphosphonate, Zometa®(Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate | Cancer Investigation | 2002 | 170 |
41 | Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer | Cancer Investigation | 2008 | 170 |
42 | The Role of Inadequate Health Literacy Skills in Colorectal Cancer Screening | Cancer Investigation | 2001 | 169 |
43 | A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer | Cancer Investigation | 2000 | 166 |
44 | Management of Cancer-Related Fatigue | Cancer Investigation | 2005 | 166 |
45 | Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies | Cancer Investigation | 2017 | 164 |
46 | Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA | Cancer Investigation | 2003 | 159 |
47 | Long-Term Administration of Mifepristone (RU486): Clinical Tolerance During Extended Treatment of Meningioma | Cancer Investigation | 2006 | 159 |
48 | Bryostatin-1: A Novel PKC Inhibitor in Clinical Development | Cancer Investigation | 2003 | 157 |
49 | MiR-146b-5p Suppresses EGFR Expression and ReducesIn VitroMigration and Invasion of Glioma | Cancer Investigation | 2010 | 157 |
50 | Clinical Science Review: Comparative Review of 5-HT3Receptor Antagonists in the Treatment of Acute Chemotherapy-Induced Nausea and Vomiting | Cancer Investigation | 2000 | 152 |